Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infar
Authors : Ruff CT; Giugliano RP; Antman EM; Crugnale SE; Bocanegra T; Mercuri M; Hanyok J; Patel I; Shi M; Salazar D; McCabe CH;
Affiliations : TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA Reprint requests: Christian T. Ruff, MD, TIMI Study Group, 350 Longwood Ave, 1st Floor Offices, Boston, MA 02115. for the ENGAGE AF-TIMI 48 Investigators. See Appendix B for complete listing. cruff@partners.org
Journal : American Heart Journal (2010)
Related Links: Pubmed | Publisher website
Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79?808 patients
Authors :
Affiliations : Unidad de Epidemiología Clínica y Estadística, Grupo Orońo, Rosario, Argentina Instituto Cardiovascular de Rosario, Rosario, Argentina Instituto de Investigaciones Clínicas, Rosario, Argentina Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Journal : N/A (2013)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...